OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.
Our Stocks to Watch today include USA Superior Energy Holdings Inc. (OTCBB: USSUE), TapImmune Inc. (OTCBB: TPIM), Progress Watch Corp. (OTC: PROW), IDM Pharma Inc. (NASD: IDMI), Fremont General Corp. (OTC: FMNT)
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/
USA SUPERIOR ENERGY (OTCBB: USSUE)
Detailed Quote: http://www.otcpicks.com/quotes/USSUE.php
Company Profile:
http://www.otcpicks.com/usa-superior-energy/usa-superior-energy-3.htm
USA Superior Energy Holdings, Inc., a development stage company, operates in the energy industry in the United States. The company, through its wholly owned subsidiary, USA Superior Energy, Inc., engages in the development, ownership, and operation of prospects and energy projects in East and Southeast Texas. It also focuses on using nitrogen technology to recharge and produce oil and gas from under-pressured partially depleted reservoirs. The company was founded in 2005 and is based in Houston, Texas.
TAPIMMUNE INCORPORATED (OTCBB: TPIM)
"Up 41.94% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/TPIM.php
TapImmune is a biotechnology company specializing in the development of innovative therapeutics and vaccines in the areas of oncology and infectious disease. The company's lead product, TAP vaccine, performs a key step in moving characteristic markers called antigens to the surfaces of cells. TAP, or Transporters Associated with Antigen Processing, are proteins responsible for supplying tumor-associated antigens (markers) and viral antigens to the surface of infected cells. Without TAP, there are no cancer markers, so the immune system fails to spot the rogue cells and the cancerous cells can grow undetected. The Company's vaccine has shown, in preclinical tests, effective restoration of TAP which restores and augments the marker (antigen) presentation and subsequent recognition and killing of cancer cells by the immune system. The TAP molecule also works as an adjuvant or 'accelerant' to enhance targeted vaccines against infectious diseases. The global vaccine market is expected to grow from $13 billion in 2007 to $21 billion in 2010. TapImmune is preparing GLP manufactured materials for the commencement of toxicology studies on the AdhTAP vaccine, leading to the initiation of a Phase I clinical trial. The Company is also developing a TAP-based vaccine adjuvant which existing preclinical data suggest increases the efficacy of targeted prophylactic vaccines by up to 1000 times. Additional information on the Company can be found on its Web site at http://www.tapimmune.com/.
PROGRESS WATCH CORPORATION (OTC: PROW)
"Up 51.22% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/PROW.php
Progress Watch Corporation (PROW) is a company dedicated to independently provide high end, innovative, reliable, stable, flexible and unique Swiss made mechanical watch movements to the elite of the Swiss watch industry.
IDM PHARMA INCORPORATED (NASD: IDMI)
"Up 7.66% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IDMI.php
IDM Pharma, Inc., a biopharmaceutical company, engages in the development of products to treat and control cancer. It develops product candidates to destroy residual cancer cells and to stimulate an immune response and prevent tumor recurrence. The company's products include L-MTP-PE/MEPACT, a Phase 3 clinical trial completed liposomal muramyl-tripeptide phosphatidylethanol- amine, for the treatment of osteosarcoma; BEXIDEM, a Phase 2 clinical trial completed product for the treatment of bladder cancer; UVIDEM, a Phase 2 clinical trial dendritophage and melanoma tumor cell lysates product, for the treatment of melanoma; IDM-2101, a multiple tumor-associated CTL epitopes Phase 2 clinical trial product, for the treatment of non-small cell lung cancer; and COLLIDEM, a Phase 1/2 dendritophages and tumor associated antigen peptides product, for the treatment of colorectal cancer. It has operations in the United States and France. IDM Pharma has collaboration agreements with sanofi-aventis S.A; Medarex, Inc.; GenPharm International, Inc.; Novartis; and Biotecnol S.A. It also has intellectual property licensing and framework agreement with Institut de Recherche Pierre Fabre and Pierre Fabre Medicament S.A. The company was incorporated in 1987 and is based in Irvine, California.
FREMONT GENERAL CORPORATION (OTC: FMNT)
"Up 64.06% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/FMNT.php
Fremont General Corporation operates as a financial services holding company in the United States. The company, through its subsidiary, Fremont General Credit Corporation, owns a California bank subsidiary, Fremont Investment & Loan, which provides various financial services. It offers certificates of deposit, savings accounts, and money market deposit accounts insured by the Federal Deposit Insurance Corporation through its 22 branches in California. The company was founded in 1963. It was formerly known as Lemac Corporation and changed its name to Fremont General Corporation in 1973. The company is based in Brea, California.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks.com has been compensated sixty thousand free trading shares by a non-controlling third party for USSUE advertising and promotional services.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
